Navigation Links
Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis
Date:4/28/2011

USRDS registry, including those patients who either had Medicare as the primary payer for greater than three months before DHHD initiation or began renal replacement therapy less than six months before initiation. Unique to this study is the detailed matching process the researchers developed based on an ordered set of covariates that could impact mortality. These covariates included age, hospital days during preceding three months, epoetin alfa dose during preceding three months, body mass index, transplant waiting list status, congestive heart failure, renal replacement therapy duration, race, cancer, primary End Stage Renal Disease (ESRD) cause, stroke, peripheral vascular disease, other cardiac disease, diabetes, ischemic heart disease, gender and dual eligibility for Medicare and Medicaid.

"We commend Dr. Collins and the CDRG for conducting the largest, broadest, most rigorously analyzed study of survival in the daily home hemodialysis population to date," said Jeffrey H. Burbank, Chief Executive Officer, NxStage Medical Inc. "This study reaffirms our belief that the clinical evidence overwhelmingly supports the significant benefits of more frequent dialysis with the System One at home.  We look forward to continue to work with policy makers to ensure patient access to this life-changing therapy."

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. NxStage is leading the development of the home hemodialysis market in the US with the only portable hemodialysis machine, the System One, cleared for home use by the FDA. For more information on NxStage and its products, please visit the company's website at

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea
2. DURECT Announces ELADUR® (TRANSDUR®-Bupivacaine) Phase II Study Results in Chronic Low Back Pain
3. Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions
4. BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
5. Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
6. AmeriCares and AstraZeneca Work Together Delivering Critical Medicines to Help People Living with Chronic Diseases in the U.S.
7. Symposium Highlights Evolving Landscape of Chronic Opioid Therapy
8. Study of Patients on Chronic Opioid Therapy finds Likely Non-adherent Patients Have Increased Healthcare Costs, More Hospital Days
9. UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
10. FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
11. Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... LEHIGH VALLEY, Pa. , July 7, 2015  Air ... efficiency of its medical oxygen supply systems—including high efficiency systems ... the 52 nd ASHE Annual Conference and Technical Exhibition ... ASHE attendees are invited to stop by ... help reduce their oxygen usage by as much as 30 ...
(Date:7/7/2015)... , June 30, 2015 ... of the "Outlook of Global Biologic Drug Discovery ... The global biologic drug discovery outsourcing market will likely ... 2020, and may reach $11.4 B by 2020. ... biologics (or biopharmaceuticals) have become a new but important ...
(Date:7/7/2015)... , July 7, 2015 Biobanks ... Helping Your Influence  ,Are you interested ... so, now gain technological and commercial predictions from 2015. ... explore trends in research and development, results, opportunities and ... visiongain shows you what,s possible for biobanking and ...
Breaking Medicine Technology:Air Products Highlights Reliability and Efficiency of Its Medical Oxygen Supply Systems at ASHE Conference and Exhibition 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10
(Date:7/7/2015)... ... July 07, 2015 , ... ... strategy expert Jay Warden as Senior Vice President, heading the firm’s Healthcare Advisory ... provide the best solutions to healthcare providers’ needs in ways that strengthen their ...
(Date:7/7/2015)... Dallas, TX (PRWEB) , ... July 07, 2015 , ... Ticket Down is a reputable ... Panama vs. Haiti and the United States vs. Honduras at the Toyota Stadium. ... today, July 7th at Toyota Stadium. The tournament, being held on American soil, will ...
(Date:7/7/2015)... ... ... Greatist today announced the acquisition of Blood, Sweat & ... fun activities to do with friends. , The acquisition of BSC strengthens Greatist’s leadership ... events, e-commerce, and brand partnerships. , “I’ve been a huge fan of Blood, Sweat ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today ... to access its antibody combination therapy (ACT) technology platform. The platform has ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is proud to announce the ... anesthesiologist and pain management specialist, will be evaluating and treating patients with orthopedic complaints, ... After receiving his Bachelor of Science in Biology from the University of the East, ...
Breaking Medicine News(10 mins):Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3
... and old ones put to new use, offer doctors ... Studies presented at the 2008 Annual Meeting of the ... and progress against brain, colorectal, rectal and ovarian cancers ... Multidisciplinary Phase II Study of AZD2171 (cediranib), an Oral ...
... Founded, YARDLEY, Pa., April 15 Breakaway ... solutions, today,announced that 2008 marks its 10th anniversary. ... the past 10 years., "Breakaway was founded ... their business problems, whether they needed a technology ...
... CHAPEL HILL, N.C., April 15 With companies across ... from the largest part of their budget - Human ... HR functions and yet retain,high service quality for the ... help executives and managers in pharma and other sectors ...
... the bodys immune system to shrink tumors and prevent new ... of the American Association for Cancer Research, April 12-16, detail ... treatment landscape. , , The first use ... , Phase I/II trial results have shown that ...
... found in materials such as paints, printing and ... world, and is thought to damage the central ... memory, attention and psychomotor function, frequently persists even ... as chronic solvent-induced encephalopathy (CSE). Although CSE is ...
... HUNTSVILLE, Ala., April 15 Open Biosystems, ... science research,tools for drug discovery, today announced ... pools for multiplexed RNAi screens. This,novel offering ... and,the ability to rapidly screen through thousands ...
Cached Medicine News:Health News:Drugs in the pipeline: new therapies that could change treatment strategies 2Health News:Drugs in the pipeline: new therapies that could change treatment strategies 3Health News:Drugs in the pipeline: new therapies that could change treatment strategies 4Health News:Drugs in the pipeline: new therapies that could change treatment strategies 5Health News:Drugs in the pipeline: new therapies that could change treatment strategies 6Health News:Breakaway Technologies Celebrates 10 Years in Business 2Health News:Using HR Performance Metrics to Drive Costs Down Across HR Functions 2Health News:Immunotherapy: enlisting the immune system to fight cancer 2Health News:Immunotherapy: enlisting the immune system to fight cancer 3Health News:Immunotherapy: enlisting the immune system to fight cancer 4Health News:Immunotherapy: enlisting the immune system to fight cancer 5Health News:Immunotherapy: enlisting the immune system to fight cancer 6Health News:Disturbances in brain circuitry linked to chronic exposure to solvents 2Health News:Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens 2
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTC/1Q chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTT/1P chairs are recommended for the ... room, static control, health care and ...
Medicine Products: